Ms. Philbin advises clients on regulatory and compliance issues including those related to clinical trials, pre-market submissions, the Quality System Regulation, Medical Device Reporting, recalls, product importing and exporting, and product promotion. Ms. Philbin assists clients in responding to agency investigations and in filing comments with FDA to respond to various regulatory initiatives. She reviews SEC filings of FDA-regulated companies and conducts due diligence of companies as part of mergers and acquisitions and initial public offerings. Ms. Philbin also assists in litigation.
Ms. Philbin is a member of the D.C. Bar Association. She is on the advisory board of BNA, Inc.’s Medical Devices Law & Industry Report.
Prior to joining Goodwin, Ms. Philbin was counsel at Wilmer Cutler Pickering Hale and Dorr. Ms. Philbin is a former instructor at Georgetown University Law Center’s Foundations for Foreign Lawyers.